Skip to main content
Top
Published in: Acta Diabetologica 3/2015

01-06-2015 | Original Article

Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative

Authors: Maria Chiara Rossi, Riccardo Candido, Antonio Ceriello, Antonino Cimino, Paolo Di Bartolo, Carlo Giorda, Katherine Esposito, Giuseppe Lucisano, Marina Maggini, Edoardo Mannucci, Illidio Meloncelli, Antonio Nicolucci, Fabio Pellegrini, Marco Scardapane, Giacomo Vespasiani

Published in: Acta Diabetologica | Issue 3/2015

Login to get access

Abstract

Objective

Quality of care monitoring is a key strategy for health policy. In Italy, the AMD Annals continuous monitoring and quality improvement initiative has been in place since 2006. Results after 8 years are now available.

Research design and methods

Quality of diabetes care indicators during the years 2004–2011 were extracted from electronic medical records of 300 diabetes clinics. From 200,000 to 500,000 patients with type 2 diabetes were analyzed per year. Six process indicators, eight intermediate outcome indicators, seven indicators of treatment intensity/appropriateness, and a quality of care summary score (Q score) were evaluated. Previous studies documented that the risk of developing a new cardiovascular event was 80 % higher in patients with a Q score <15 and 20 % higher in those with a score between 15 and 25, as compared to those with a score >25.

Results

The proportion of patients with HbA1c ≤7 %, LDL cholesterol <100 mg/dl, and blood pressure ≥140/90 mmHg increased by 4.8, 21.9, and 10.0 %, respectively. Process and treatment intensity/appropriateness indicators consistently improved. The proportion of patients with a Q score <15 decreased from 13.5 to 6.5 %, while those with a Q score >25 increased from 22.9 to 38.5 %.

Conclusions

AMD Annals document the progress in quality of diabetes care. Longitudinal improvements in Q score can translate into less cardiovascular events, with evident clinical and economic implications. AMD Annals represent a physician-led effort not requiring allocation of extra-economic resources, which is easy to implement and deeply rooted in routine clinical practice. They are a potential case model for other healthcare systems.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
2.
go back to reference King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed
3.
go back to reference Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F (2000) Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50(Suppl 2):S77–S84PubMed Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F (2000) Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50(Suppl 2):S77–S84PubMed
4.
go back to reference Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMed Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMed
5.
go back to reference Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787CrossRefPubMed Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787CrossRefPubMed
6.
go back to reference Fagot-Campagna A, Bourdel-Marchasson I, Simon D (2005) Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2:5S35–5S52 Fagot-Campagna A, Bourdel-Marchasson I, Simon D (2005) Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2:5S35–5S52
8.
go back to reference Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMed Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMed
9.
go back to reference Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE (2005) Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 22:1379–1385PubMed Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE (2005) Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 22:1379–1385PubMed
10.
go back to reference Huang ES, Basu A, O’Grady M, Capretta JC (2009) Projecting the future diabetes population size and related costs for the US. Diabetes Care 32:2225–2229CrossRefPubMedCentralPubMed Huang ES, Basu A, O’Grady M, Capretta JC (2009) Projecting the future diabetes population size and related costs for the US. Diabetes Care 32:2225–2229CrossRefPubMedCentralPubMed
12.
go back to reference Giorda CB, Manicardi V, Diago Cabezudo J (2011) The impact of diabetes mellitus on healthcare costs in Italy. Expert Rev Pharmacoecon Outcomes Res 11:709–719PubMed Giorda CB, Manicardi V, Diago Cabezudo J (2011) The impact of diabetes mellitus on healthcare costs in Italy. Expert Rev Pharmacoecon Outcomes Res 11:709–719PubMed
13.
go back to reference Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45:S5–S12CrossRefPubMed Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45:S5–S12CrossRefPubMed
14.
15.
go back to reference Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM (2004) Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 27:694–698CrossRefPubMed Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM (2004) Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 27:694–698CrossRefPubMed
16.
go back to reference Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, for TRIAD Study Group et al (2006) The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 145:107–116PubMed Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, for TRIAD Study Group et al (2006) The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 145:107–116PubMed
17.
go back to reference De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, for the QuED Study et al (2004) Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 27:398–406CrossRefPubMed De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, for the QuED Study et al (2004) Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 27:398–406CrossRefPubMed
18.
go back to reference Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA (2001) The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24:1815–1820CrossRefPubMed Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA (2001) The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24:1815–1820CrossRefPubMed
19.
go back to reference Nicolucci A, Greenfield S, Mattke S (2006) Selecting indicators for the quality of diabetes care at the health systems level in OECD countries. Int J Qual Health Care 18(Suppl 1):26–30PubMed Nicolucci A, Greenfield S, Mattke S (2006) Selecting indicators for the quality of diabetes care at the health systems level in OECD countries. Int J Qual Health Care 18(Suppl 1):26–30PubMed
20.
go back to reference Ekström N, Miftaraj M, Svensson AM, Andersson Sundell K, Cederholm J, Zethelius B et al (2012) Glucose-lowering treatment and clinical results in 163121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register. Diabetes Obes Metab 14:717–726PubMed Ekström N, Miftaraj M, Svensson AM, Andersson Sundell K, Cederholm J, Zethelius B et al (2012) Glucose-lowering treatment and clinical results in 163121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register. Diabetes Obes Metab 14:717–726PubMed
21.
go back to reference Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M et al (2012) Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 35:774–779CrossRefPubMedCentralPubMed Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M et al (2012) Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 35:774–779CrossRefPubMedCentralPubMed
22.
go back to reference Guthrie B, Emslie-Smith A, Morris AD (2009) Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med 26:1269–1276PubMed Guthrie B, Emslie-Smith A, Morris AD (2009) Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med 26:1269–1276PubMed
23.
go back to reference Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:1613–1624PubMed Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:1613–1624PubMed
24.
go back to reference Club Diabete Sicili@ (2008) Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics. Diabetes Care 31:57–62CrossRef Club Diabete Sicili@ (2008) Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics. Diabetes Care 31:57–62CrossRef
25.
go back to reference Rossi MC, Nicolucci A, Arcangeli A, Cimino A, De Bigontina G, Giorda C, For the Associazione Medici Diabetologi Annals Study Group et al (2008) Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics. Diabetes Care 31:2166–2168CrossRefPubMedCentralPubMed Rossi MC, Nicolucci A, Arcangeli A, Cimino A, De Bigontina G, Giorda C, For the Associazione Medici Diabetologi Annals Study Group et al (2008) Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics. Diabetes Care 31:2166–2168CrossRefPubMedCentralPubMed
26.
go back to reference Nicolucci A, Rossi MC, Arcangeli A, Cimino A, de Bigontina G, Fava D, For AMD-Annals Study Group et al (2010) Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med 27:1041–1048PubMed Nicolucci A, Rossi MC, Arcangeli A, Cimino A, de Bigontina G, Fava D, For AMD-Annals Study Group et al (2010) Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med 27:1041–1048PubMed
27.
go back to reference Giorda CB, Mulas MF, Manicardi V, Suraci C, Guida P, Marafetti L, Nada E, Gentile S (2013) Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting. Acta Diabetol 50:81–87PubMed Giorda CB, Mulas MF, Manicardi V, Suraci C, Guida P, Marafetti L, Nada E, Gentile S (2013) Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting. Acta Diabetol 50:81–87PubMed
28.
go back to reference Suraci C, Mulas F, Rossi MC, Gentile S, Giorda CB (2012) Management of newly diagnosed patients with type 2 diabetes: what are the attitudes of physicians? A SUBITO!AMD survey on the early diabetes treatment in Italy. Acta Diabetol 49:429–433PubMed Suraci C, Mulas F, Rossi MC, Gentile S, Giorda CB (2012) Management of newly diagnosed patients with type 2 diabetes: what are the attitudes of physicians? A SUBITO!AMD survey on the early diabetes treatment in Italy. Acta Diabetol 49:429–433PubMed
30.
go back to reference Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K (2012) Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 156:785–795PubMed Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K (2012) Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 156:785–795PubMed
31.
go back to reference O’Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E et al (2011) Diabetes performance measures: current status and future directions. Diabetes Care 34:1651–1659CrossRefPubMedCentralPubMed O’Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E et al (2011) Diabetes performance measures: current status and future directions. Diabetes Care 34:1651–1659CrossRefPubMedCentralPubMed
33.
go back to reference De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, For the QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group et al (2008) Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study. Nutr Metab Cardiovasc Dis 18:57–65PubMed De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, For the QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group et al (2008) Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study. Nutr Metab Cardiovasc Dis 18:57–65PubMed
34.
go back to reference Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, For the AMD-QUASAR Study Group et al (2011) Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care 34:347–352CrossRefPubMedCentralPubMed Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, For the AMD-QUASAR Study Group et al (2011) Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care 34:347–352CrossRefPubMedCentralPubMed
35.
go back to reference Giorda CB, Nicolucci A, Pellegrini F, Kristiansen CK, Hunt B, Valentine WJ et al (2014) Improving quality of care in people with type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis. Diabet Med 31:615–623PubMed Giorda CB, Nicolucci A, Pellegrini F, Kristiansen CK, Hunt B, Valentine WJ et al (2014) Improving quality of care in people with type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis. Diabet Med 31:615–623PubMed
Metadata
Title
Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative
Authors
Maria Chiara Rossi
Riccardo Candido
Antonio Ceriello
Antonino Cimino
Paolo Di Bartolo
Carlo Giorda
Katherine Esposito
Giuseppe Lucisano
Marina Maggini
Edoardo Mannucci
Illidio Meloncelli
Antonio Nicolucci
Fabio Pellegrini
Marco Scardapane
Giacomo Vespasiani
Publication date
01-06-2015
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2015
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0688-6

Other articles of this Issue 3/2015

Acta Diabetologica 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.